Angiotech To Participate In The American Academy Of Ophthalmology (AAO) 2007 Annual Meeting



    Introducing SharpGuard(TM) Microsurgical Guarded Knives For Use In
    Ophthalmic Surgery

    VANCOUVER, Nov. 8 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:   ANPI,
TSX: ANP), a global specialty pharmaceutical and medical device company, today
announced that it plans to exhibit its SharpGuard(TM) product line as well as
all of its Sharpoint(TM) brand ophthalmic disposable surgical instruments at
the upcoming American Academy of Ophthalmology (AAO) annual meeting.

    About the SharpGuard(TM) Guarded Knives Product Line

    The SharpGuard(TM) product line is comprised of microsurgical guarded
knives for use in ophthalmic surgery. Key features of the SharpGuard(TM)
product line include:

    
    -   Guarded sheath designed to eliminate or minimize sharps injuries

    -   Sharpoint(TM) premium quality microsurgical blades manufactured by
        proprietary Infinite Edge(TM) technology process

    -   Ergonomic grip designed for precise control and comfort

    -   Designed to comply with OSHA bloodborne pathogens regulations
    

    Angiotech will host Booth No. 2411 at the AAO annual meeting in New
Orleans, LA, taking place from November 10-13, 2007.

    About Angiotech

    Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ:   ANPI, TSX: ANP),
please visit our website at www.angiotech.com.

    SHARPGUARD(TM), SHARPOINT(TM) and INFINITE EDGE(TM) are trademarks of
    Surgical Specialties Corporation, a wholly-owned subsidiary of Angiotech
    Pharmaceuticals, Inc.
    (C)2007 Angiotech Pharmaceuticals, Inc. (C)2007 Surgical Specialties
    Corporation. All Rights Reserved.




For further information:

For further information: Jodi Regts, Senior Manager, Investor Relations
and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,
jregts@angio.com

Organization Profile

Angiotech Pharmaceuticals, Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890